Repository logo

Statistics for A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND)

Total visits

views
A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND) 43

Total visits per month

views
December 2024 1
January 2025 0
February 2025 0
March 2025 0
April 2025 0
May 2025 0
June 2025 0

File Visits

views
RESPOND_ArticleOphthalmicResearch_2017.pdf(legacy) 186
MAJOR RIBEIRO FARIA.pdf(legacy) 1
Dissertação Sília MLPO.pdf(legacy) 1
RESPOND_ArticleOphthalmicResearch_2017.pdf 1

Top country views

views
United States 19
Portugal 8
China 7
France 1
United Kingdom 1
Hong Kong SAR China 1
Ireland 1
India 1
Mexico 1
New Zealand 1